References
- Brainard, J., and J. You. 2018. “What a Massive Database of Retracted Papers Reveals about Science Publishing’s ‘Death Penalty’.” https://www.sciencemag.org/news/2018/10/what-massive-database-retracted-papers-reveals-about-science-publishing-s-death-penalty
- Dal-Ré, R., and C. Ayuso. 2019. “Reasons for and Time to Retraction of Genetics Articles Published between 1970 and 2018.” Journal of medical genetics 56: 734–740. doi:https://doi.org/10.1136/jmedgenet-2019-106137.
- Fihn, S. D., E. Perencevich, and S. M. Bradley. 2020. “Caution Needed on the Use of Chloroquine and Hydroxychloroquine for Coronavirus Disease 2019.” JAMA Network Open 3 (4): e209035. doi:https://doi.org/10.1001/jamanetworkopen.2020.9035.
- Hirano, T., and M. Murakami. 2020. “COVID-19: A New Virus, but A Familiar Receptor and Cytokine Release Syndrome.” Immunity 52 (5): 731–733. doi:https://doi.org/10.1016/j.immuni.2020.04.003.
- Kakodkar, P., N. Kaka, and M. N. Baig. 2020. “A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19).” Cureus 12: e7560. doi:https://doi.org/10.7759/cureus.7560.
- The Lancet Editors. 2020. “Expression of Concern: Hydroxychloroquine or Chloroquine with or without A Macrolide for Treatment of COVID-19: A Multinational Registry Analysis.” Lancet S0140-6736 (20): 31290–31293. doi:https://doi.org/10.1016/S0140-6736(20)31290-3.
- Ledford, H. 2020. “Chloroquine Hype Is Derailing the Search for Coronavirus Treatments.” https://www.nature.com/articles/d41586-020-01165-3
- Li, H., Z. Liu, and J. Ge. 2020. “Scientific Research Progress of COVID-19/SARS-CoV-2 in the First Five Months.” Journal of Cellular and Molecular Medicine. doi:https://doi.org/10.1111/jcmm.15364.
- Magagnoli, J., S. Narendran, et al. 2020. “Outcomes of Hydroxychloroquine Usage in United States Veterans Hospitalized with Covid-19.” medRxiv. doi:https://doi.org/10.1101/2020.04.16.20065920v2.
- Molina, J. M., C. Delaugerre, J. Le Goff, B. Mela-Lima, D. Ponscarme, L. Goldwirt, and N. de Castro. 2020. “No Evidence of Rapid Antiviral Clearance or Clinical Benefit with the Combination of Hydroxychloroquine and Azithromycin in Patients with Severe COVID-19 Infection.” Médecine et Maladies Infectieuses 50 (4): 384. doi:https://doi.org/10.1016/j.medmal.2020.03.006.
- Reuters Fact Check team. 2020. “True Claim: Brazilian Chloroquine Study on COVID-19 Patients Was Halted after 11 Deaths.” https://www.reuters.com/article/uk-factcheck-brazilian-chloroquine-study/true-claimbrazilian-chloroquine-studyon-covid-19-patients-washalted-after11deaths-idUSKBN21Z395
- Richt, J. A., R. J. Webby, and R. E. Kahn. 2013. “The Pandemic H1N1 Influenza Experience.” Current Topics in Microbiology and Immunology 365: 269–279. doi:https://doi.org/10.1007/82_2013_309.
- Trikalinos, N. A., E. Evangelou, and J. P. A. Ioannidis. 2008. “Falsified Papers in High-impact Journals Were Slow to Retract and Indistinguishable from Nonfraudulent Papers.” Journal of Clinical Epidemiology 61 (5): 464–470. doi:https://doi.org/10.1016/j.jclinepi.2007.11.019.
- Wellcome Trust. 2020. “Sharing Research Data and Findings Relevant to the Novel Coronavirus (COVID-19) Outbreak.” https://wellcome.ac.uk/coronavirus-covid-19/open-data